Literature DB >> 7793313

p53: a cell cycle regulator activated by DNA damage.

G Selivanova1, K G Wiman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7793313     DOI： 10.1016/s0065-230x(08)60253-5

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  20 in total

1.  CD3-epsilon overexpressed in prothymocytes acts as an oncogene.

Authors:  B Wang; J She; M Salio; D Allen; E Lacy; N Lonberg; C Terhorst
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter.

Authors:  J Bian; Y Sun
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  The single-stranded DNA end binding site of p53 coincides with the C-terminal regulatory region.

Authors:  G Selivanova; V Iotsova; E Kiseleva; M Ström; G Bakalkin; R C Grafström; K G Wiman
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

4.  p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity.

Authors:  P Röhlke; K Milde-Langosch; C Weyland; U Pichlmeier; W Jonat; T Löning
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 5.  Regulation of p53 by protein kinase C during multi-stage carcinogenesis.

Authors:  L Magnelli; V Chiarugi
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53.

Authors:  S Bialik; D L Geenen; I E Sasson; R Cheng; J W Horner; S M Evans; E M Lord; C J Koch; R N Kitsis
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

7.  DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.

Authors:  S Y Shieh; Y Taya; C Prives
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

Review 8.  p53 gene in treatment of hepatic carcinoma: status quo.

Authors:  Yong-Song Guan; Zi La; Lin Yang; Qing He; Ping Li
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

9.  Illegitimate recombination leading to allelic loss and unbalanced translocation in p53-mutated human lymphoblastoid cells.

Authors:  M Honma; L S Zhang; M Hayashi; K Takeshita; Y Nakagawa; N Tanaka; T Sofuni
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

10.  Apoptosis-associated genes related to photodynamic therapy in breast carcinomas.

Authors:  J C Silva; J Ferreira-Strixino; L C Fontana; L M Paula; L Raniero; A A Martin; R A Canevari
Journal:  Lasers Med Sci       Date:  2014-02-27       Impact factor: 3.161
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.